亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 土霉素 CAS號: 79-57-2
土霉素 CAS號: 79-57-2
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 79-57-2
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息

土霉素
CAS號: 79-57-2
中文同義詞: 4-(二甲基氨基)-1,4,4A,5,5A,6,11,12A-八氫-3,5,6,10,12,12A-六羥基-6-甲基-1,11-二羰基-[4S-(4α,4Aα,5α,5Aα,6β,12Aα)]-2-萘甲酰胺;土霉素堿;土霉素;氧四環素;地靈黴素;4-二甲氨基-1,4,4a,5,5a,6,11,12a-八氫-3,5,6,10,12,12a-六羥基-6-甲基-1,11-二氧代-并四苯-2-甲酰胺;地霉素;氧四環素
英文名稱: Oxytetracycline
英文同義詞: 12,12a-hexahydroxy-6-methyl-1,11-dioxo-10;4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,2-Naphthacenecarboxamide;5-hydroxy-tetracyclin;6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,(4s-(4-alpha,4a-alpha,5-alpha,5a;6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,[4s-(4alpha,4aalpha,5alpha,5a;6-beta,12a-alpha))--alph;adamycin;antibiotictm25
分子式: C22H24N2O9
分子量: 460.43
EINECS號: 201-212-8
含量:≥95%
性狀;本品為淡黃色或黃色結晶星粉末。
標準:中國衛生部89版/英國藥典2002版/歐洲藥典V版
適應癥:抗生素類藥。有廣譜抑菌作用 。主要用于立克次體病、布氏桿菌病、支原體肺炎、衣原體屬感染,也可用于敏感革蘭氏陽性球菌與陰性桿菌引起的輕癥感染。
包裝:25公斤/袋。
©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31078  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |